Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 36 results:
Συντάκτης [ Τίτλος] Τύπος Έτος Φίλτρα: Συντάκτης is Liakos, Aris [Clear All Filters]
Use of the Diabetes Medication Choice Decision Aid in patients with type 2 diabetes in Greece: a cluster randomised trial..
BMJ Open. 6(11), e012185.
(2016). Use of the Diabetes Medication Choice Decision Aid in patients with type 2 diabetes in Greece: a cluster randomised trial.
BMJ Open. 6(11), e012185.
(2016). Update on long-term efficacy and safety of dapagliflozin in patients with type 2 diabetes mellitus..
Ther Adv Endocrinol Metab. 6(2), 61-7.
(2015). Ultra-rapid-acting insulins for adults with diabetes: A systematic review and meta-analysis..
Diabetes Obes Metab. 23(10), 2395-2401.
(2021). Systematic review and meta-analysis of vildagliptin for treatment of type 2 diabetes.
Endocrine. 458 - 480.
(2016). Sotagliflozin for patients with type 2 diabetes: A systematic review and meta-analysis..
Diabetes Obes Metab. 24(1), 106-114.
(2022). Some glucose-lowering drugs reduce risk for major adverse cardiac events..
Ann Intern Med. 173(2), JC9.
(2020). Sodium-glucose cotransporter 2 inhibitors for type 2 diabetes: a systematic review and meta-analysis..
Ann Intern Med. 159(4), 262-74.
(2013). A simple plaster for screening for diabetic neuropathy: a diagnostic test accuracy systematic review and meta-analysis..
Metabolism. 63(4), 584-92.
(2014). A Simple Guide to Systematic Reviews and Meta-Analyses..
Int J Low Extrem Wounds. 15347346231169842.
(2023). Semaglutide for type 2 diabetes mellitus: A systematic review and meta-analysis..
Diabetes Obes Metab. 20(9), 2255-2263.
(2018). Semaglutide for type 2 diabetes mellitus: a systematic review and meta-analysis.
Diabetes, Obesity and Metabolism.
(2018).
(2023).
Preferred reporting items for overviews of systematic reviews including harms checklist: a pilot tool to be used for balanced reporting of benefits and harms..
J Clin Epidemiol. 93, 9-24.
(2018). Preferred reporting items for overviews of systematic reviews including harms checklist: a pilot tool to be used for balanced reporting of benefits and harms.
Journal of Clinical Epidemiology. 93, 9 - 24.
(2018). Management of type 2 diabetes with the dual GIP/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysis..
Diabetologia. 65(8), 1251-1261.
(2022). Management of type 2 diabetes in the new era..
Hormones (Athens). 22(4), 677-684.
(2023). In type 2 diabetes, SGLT2 inhibitors were linked to diabetic ketoacidosis vs. DPP-4 inhibitors..
Ann Intern Med. 173(12), JC70.
(2020). Glucagon-like peptide-1 receptor agonists and sodium-glucose co-transporter-2 inhibitors as combination therapy for type 2 diabetes: A systematic review and meta-analysis..
Diabetes Obes Metab. 22(10), 1857-1868.
(2020). GLP-1 receptor agonists for cardiovascular outcomes with and without metformin. A systematic review and meta-analysis of cardiovascular outcomes trials..
Diabetes Res Clin Pract. 177, 108921.
(2021). GLP-1 receptor agonists and SGLT2 inhibitors for older people with type 2 diabetes: A systematic review and meta-analysis..
Diabetes Res Clin Pract. 174, 108737.
(2021). Fixed ratio combinations of glucagon like peptide 1 receptor agonists with basal insulin: a systematic review and meta-analysis..
Endocrine. 56(3), 485-494.
(2017). Fixed ratio combinations of glucagon like peptide 1 receptor agonists with basal insulin: a systematic review and meta-analysis.
Endocrine. 5625815134372239371731583439396341596(31134341111109129114943), 485 - 494.
(2017). Evaluation of the Greek TranQol: a novel questionnaire for measuring quality of life in transfusion-dependent thalassemia patients..
Ann Hematol. 96(11), 1937-1944.
(2017). Evaluation of the Greek TranQol: a novel questionnaire for measuring quality of life in transfusion-dependent thalassemia patients.
Annals of Hematology. 9635386959511886953716410511460363056271262012394215457(1111435131343Suppl 21151168618233445), 1937 - 1944.
(2017).